We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The Antman/Hassan/Eisner et al Article Reviewed.
- Authors
Vogelzang, Nicholas J.; Manno, Phillip J.
- Abstract
Offers views on a study related to mesothelioma. Information that the largest phase III trial ever conducted in pleural mesothelioma showed that median survival improved by nearly 4 months for pemetrexed/cisplatin recipients; View that doublet chemotherapy is substantially superior to single-agent chemotherapy; Finding that the vast majority of patients with malignant pleural mesothelioma die of their disease even with aggressive surgical therapy.
- Subjects
MESOTHELIOMA; TUMORS; IMMUNOLOGICAL adjuvants; CISPLATIN; DRUG therapy; ALKYLATING agents
- Publication
Oncology (08909091), 2005, Vol 19, Issue 10, p1313
- ISSN
0890-9091
- Publication type
Article